MARKET

CYTK

CYTK

Cytokinetics Inc
NASDAQ
38.63
+0.67
+1.77%
After Hours: 39.25 +0.62 +1.61% 18:51 06/02 EDT
OPEN
38.56
PREV CLOSE
37.96
HIGH
39.25
LOW
37.95
VOLUME
688.04K
TURNOVER
0
52 WEEK HIGH
55.80
52 WEEK LOW
32.96
MARKET CAP
3.69B
P/E (TTM)
-8.4362
1D
5D
1M
3M
1Y
5Y
Mizuho Securities Remains a Buy on Cytokinetics (CYTK)
TipRanks · 1d ago
Cytokinetics Inc: Statement of changes in beneficial ownership of securities
Press release · 2d ago
Cytokinetics (CYTK) Gets a Buy from Mizuho Securities
TipRanks · 05/26 11:35
Cytokinetics Inc: Current report
Press release · 05/23 11:10
HC Wainwright & Co. Reiterates Cytokinetics (CYTK) Buy Recommendation
NASDAQ · 05/22 20:18
JMP Securities Reiterates Cytokinetics (CYTK) Market Outperform Recommendation
NASDAQ · 05/22 20:18
What 20 Analyst Ratings Have To Say About Cytokinetics
Benzinga · 05/22 19:01
JMP Securities Reiterates Market Outperform on Cytokinetics, Maintains $71 Price Target
Benzinga · 05/22 12:35
More
About CYTK
Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases. It is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. The Company's clinical-stage drug candidates are: omecamtiv mecarbil, a cardiac myosin activator for the treatment of heart failure with reduced ejection fraction (HFrEF); CK-136, a cardiac troponin activator for the treatment of heart failure and other diseases; reldesemtiv , a fast skeletal muscle troponin activator (FSTA) for the treatment of people living with debilitating diseases and conditions associated with muscular weakness; aficamten, a cardiac myosin inhibitor designed to reduce the hypercontractility that is associated with hypertrophic cardiomyopathy (HCM); and CK-136 an novel small molecule cardiac troponin activator.

Webull offers kinds of Cytokinetics, Inc. stock information, including NASDAQ:CYTK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYTK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CYTK stock methods without spending real money on the virtual paper trading platform.